ENVALITH
株式会社カワチ薬品 logo

cawachi limited

2664Prime MarketRetail Trade

株式会社カワチ薬品 logo
cawachi limited2664
Reference Indicators

Market Cap

835¥100M

P/E (Forecast)

P/B

0.7x

Dividend Yield (Forecast)

2.95%

ROE

2.8%

EV/EBITDA

5.5x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
279,462281,871285,960287,816284,492
Cost of Sales
216,313217,824220,158221,098219,174
Gross Profit
63,14964,04765,80166,71765,318
SG&A Expenses
55,43957,43558,20059,25658,538
Operating Income
7,7096,6117,6017,4616,779
Non-operating Income
1,3991,4421,4601,3661,601
Non-operating Expenses
409381452487483
Ordinary Income
8,6987,6728,6098,3407,897
Extraordinary Income
014814560
Extraordinary Losses
1,0111,2481,6011,5192,326
Pre-tax Income
7,6876,5727,1536,8275,572
Income Taxes
2,8572,3942,4401,9422,371
Net Income
4,8304,1774,7134,8843,200
EBITDA
12,13310,96111,90711,95511,251
Gross Margin
22.6%22.7%23.0%23.2%23.0%
Operating Margin
2.8%2.3%2.7%2.6%2.4%
ROA
2.5%2.1%2.4%2.4%1.6%
ROE
4.7%3.9%4.3%4.3%2.8%